These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 12746701)

  • 41. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.
    Albany K
    Muscle Nerve Suppl; 1997; 6():S221-31. PubMed ID: 9826993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is there evidence that botulinum toxin injections are more effective than phenol injections in relieving poststroke reflex activity during plantar flexion, thereby increasing ankle range of motion and improving gait function?
    Cormack J; Powers CM
    Phys Ther; 2004 Jan; 84(1):76-84. PubMed ID: 14992678
    [No Abstract]   [Full Text] [Related]  

  • 43. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: grasp strategies and kinematics of reach-to-grasp movements.
    Bensmail D; Robertson J; Fermanian C; Roby-Brami A
    Neurorehabil Neural Repair; 2010 Feb; 24(2):141-51. PubMed ID: 19786722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New approaches to managing spasticity in children with cerebral palsy.
    Im D; McDonald CM
    West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
    [No Abstract]   [Full Text] [Related]  

  • 45. Spasticity treatment with botulinum toxins.
    Ward AB
    J Neural Transm (Vienna); 2008; 115(4):607-16. PubMed ID: 18389166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
    Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
    Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computerized gait analysis of botulinum toxin treatment in children with cerebral palsy.
    Galli M; Cimolin V; Valente EM; Crivellini M; Ialongo T; Albertini G
    Disabil Rehabil; 2007 Apr; 29(8):659-64. PubMed ID: 17453987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety considerations in the use of botulinum toxins in children with cerebral palsy.
    Apkon SD; Cassidy D
    PM R; 2010 Apr; 2(4):282-4. PubMed ID: 20430330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial.
    Koman LA; Mooney JF; Smith BP; Goodman A; Mulvaney T
    J Pediatr Orthop; 1994; 14(3):299-303. PubMed ID: 8006158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of botulinum toxin treatment on associated reactions of the upper limb on hemiplegic gait--a pilot study.
    Bakheit AM; Sawyer J
    Disabil Rehabil; 2002 Jul; 24(10):519-22. PubMed ID: 12171641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
    Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
    Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of botulinum toxin for the treatment of muscle spasticity in the first 2 years of life.
    Bakheit AM
    Int J Rehabil Res; 2010 Jun; 33(2):104-8. PubMed ID: 19574925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Gracies JM; Graham HK; Miyasaki JM; Naumann M; Russman B; Simpson LL; So Y;
    Neurology; 2008 May; 70(19):1691-8. PubMed ID: 18458229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neurologic indications of botulin in adults].
    Sotaniemi K
    Duodecim; 2011; 127(22):2409-14. PubMed ID: 22238918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
    Turner-Stokes L; Ashford S
    Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy.
    Criswell SR; Crowner BE; Racette BA
    Neurosurg Focus; 2006 Aug; 21(2):e1. PubMed ID: 16918222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of botulinum toxin injections in the management of muscle overactivity of the lower limb.
    Gracies JM; Singer BJ; Dunne JW
    Disabil Rehabil; 2007 Dec; 29(23):1789-805. PubMed ID: 18033604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.